©The Author(s) 2026.
World J Gastroenterol. Jan 14, 2026; 32(2): 114057
Published online Jan 14, 2026. doi: 10.3748/wjg.v32.i2.114057
Published online Jan 14, 2026. doi: 10.3748/wjg.v32.i2.114057
Table 2 Histopathological scoring criteria
| Score | Inflammation extent | Crypt damage | Ulceration | Edema |
| 0 | None | Intact crypt architecture | No ulcer | Absent |
| 1 | Scattered submucosal cells | Some crypt damage | Small focal ulcers | Present |
| 2 | Focal submucosal infiltrates | Increased crypt spacing, goblet cell loss, crypt shortening | Frequent small ulcers | |
| 3 | Focal submucosal, lamina propria infiltrates | Large crypt-deficient areas amid normal crypts | Extensive surface epithelial loss | |
| 4 | Extensive submucosal, lamina propria, perivascular infiltrates | Crypt absence | ||
| 5 | Transmural inflammation |
- Citation: Zhao YQ, Zhang Y, Qin Y, Zhang RY, Wang JP. Cedrol ameliorates ulcerative colitis via myeloid differentiation factor 2-mediated inflammation suppression, with barrier restoration and microbiota modulation. World J Gastroenterol 2026; 32(2): 114057
- URL: https://www.wjgnet.com/1007-9327/full/v32/i2/114057.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i2.114057